CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Open-market sale See Remarks sold 471,432 shares at an average $12.74 ($6,005,628)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 7,500 shares at $12.96 ($97,203)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 10,361 shares at an average $12.64 ($131,010)
- 4 Open-market sale Director sold 28,000 shares at $12.93 ($362,012)
- 4 Open-market sale See Remarks sold 16,051 shares at $12.72 ($204,127)
- 4 Open-market sale See Remarks sold 3,441 shares at $12.72 ($43,761)
- 4 Open-market sale Chief Financial Officer sold 2,423 shares at $12.72 ($30,814)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 8-K Event Executive or director change
- 4 Open-market sale See Remarks sold 6,236 shares at $13.86 ($86,431)
Page 7 of 28 · 558 filings